Cortisone Shots Market Research Report Information: By Type (Articular or Joint Injections, Epidural Steroid Injection, Trigger Point Injection), Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Tendinitis, Allergic Reaction), End User - Global Forecast till 2032

Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Cortisone shots Market, by Type

6.1 Introduction

6.2 Articular or Joint Injection

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 Epidural Steroid Injection

6.3.1 Market Estimates & Forecast, 2020-2027

6.4 Trigger Point" Injection

6.4.1 Market Estimates & Forecast, 2020-2027

7. Global Cortisone shots Market, by Indication

7.1 Introduction

7.2 Rheumatoid Arthritis

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Psoriatic Arthritis

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Bursitis

7.4.1 Market Estimates & Forecast, 2020-2027

7.5 Tendinitis

7.5.1 Market Estimates & Forecast, 2020-2027

7.6 Allergic Reaction

7.6.1 Market Estimates & Forecast, 2020-2027

7.7 Skin Conditions

7.7.1 Market Estimates & Forecast, 2020-2027

8. Global Cortisone shots Market, by End User

8.1 Introduction

8.2 Hospital

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Clinics

8.3.1 Market Estimates & Forecast, 2020-2027

8.3 Sport Medicine Centers

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Pharmaceutical Companies

8.4.1 Market Estimates & Forecast, 2020-2027

9. Global Cortisone shots Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.1 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 UK

9.3.1.4 Italy

9.3.1.5 Spain

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic of Korea

9.4.6 Rest of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest of the Middle East & Africa

10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

11 Company Profiles

11.1 Merck & Co., Inc.

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Pfizer

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Bristol-Myers Squibb Company

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Novartis AG

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 GlaxoSmithKline

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 Pharmascience Inc.

11.6.1 Overview

11.6.2 Product Overview

11.6.3 Financials

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Farmabios SPA

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 AdvaCare Pharma

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Others

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Pharmaceutical Industry

13 Appendix

LIST OF TABLES

Table 1 Cortisone shots Industry Synopsis, 2020-2027

Table 2 Global Cortisone shots Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Global Cortisone shots Market by Region, 2020-2027, (USD Million)

Table 4 Global Cortisone shots Market by Types, 2020-2027, (USD Million)

Table 5 Global Cortisone shots Market by Indication, 2020-2027, (USD Million)

Table 7 Global Cortisone shots Market by End Users, 2020-2027, (USD Million)

Table 8 North America Cortisone shots Market by Types, 2020-2027, (USD Million)

Table 9 North America Cortisone shots Market by Indication, 2020-2027, (USD Million)

Table 11 North America Cortisone shots Market by End Users, 2020-2027, (USD Million)

Table 12 US Cortisone shots Market by Types, 2020-2027, (USD Million)

Table 13 US Cortisone shots Market by Indication, 2020-2027, (USD Million)

Table 15 US Cortisone shots Market by End Users, 2020-2027, (USD Million)

Table 16 Canada Cortisone shots Market by Types, 2020-2027, (USD Million)

Table 17 Canada Cortisone shots Market by Indication, 2020-2027, (USD Million)

Table 19 Canada Cortisone shots Market by End Users, 2020-2027, (USD Million)

Table 20 South America Cortisone shots Market by Types, 2020-2027, (USD Million)

Table 21 South America Cortisone shots Market by Indication, 2020-2027, (USD Million)

Table 23 South America Cortisone shots Market by End Users, 2020-2027, (USD Million)

Table 24 Europe Cortisone shots Market by Types, 2020-2027, (USD Million)

Table 25 Europe Cortisone shots Market by Indication, 2020-2027, (USD Million)

Table 27 Europe Cortisone shots Market by End Users, 2020-2027, (USD Million)

Table 28 Western Europe Cortisone shots Market by Types, 2020-2027, (USD Million)

Table 29 Western Europe Cortisone shots Market by Indication, 2020-2027, (USD Million)

Table 31 Western Europe Cortisone shots Market by End Users, 2020-2027, (USD Million)

Table 32 Eastern Europe Cortisone shots Market by Types, 2020-2027, (USD Million)

Table 33 Eastern Europe Cortisone shots Market by Indication, 2020-2027, (USD Million)

Table 35 Eastern Europe Cortisone shots Market by End Users, 2020-2027, (USD Million)

Table 36 Asia Pacific Cortisone shots Market by Types, 2020-2027, (USD Million)

Table 37 Asia Pacific Cortisone shots Market by Indication, 2020-2027, (USD Million)

Table 39 Asia Pacific Cortisone shots Market by End Users, 2020-2027, (USD Million)

Table 40 Middle East & Africa Cortisone shots Market by Types, 2020-2027, (USD Million)

Table 41 Middle East & Africa Cortisone shots Market by Indication, 2020-2027, (USD Million)

Table 43 Middle East & Africa Cortisone shots Market by End Users, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Cortisone shots Market

Figure 3 Segmentation Market Dynamics for Cortisone shots Market

Figure 4 Global Cortisone shots Market Share, by Type, 2020

Figure 5 Global Cortisone shots Market Share, by Indication, 2020

Figure 6 Global Cortisone shots Market Share, by End Users, 2020

Figure 7 Global Cortisone shots Market Share, by Region, 2020

Figure 8 North America Cortisone shots Market Share, by Country, 2020

Figure 9 Europe Cortisone shots Market Share, by Country, 2020

Figure 10 Asia Pacific Cortisone shots Market Share, by Country, 2020

Figure 11 Middle East & Africa Cortisone shots Market Share, by Country, 2020

Figure 12 Global Cortisone shots Market: Company Share Analysis, 2020 (%)

Figure 13 Merck & Co., Inc.: Key Financials

Figure 14 Merck & Co., Inc.: Segmental Revenue

Figure 16 Merck & Co., Inc.: Geographical Revenue

Figure 17 Pfizer: Key Financials

Figure 18 Pfizer: Segmental Revenue

Figure 19 Pfizer: Geographical Revenue

Figure 20 Bristol-Myers Squibb Company: Key Financials

Figure 21 Bristol-Myers Squibb Company: Segmental Revenue

Figure 22 Bristol-Myers Squibb Company: Geographical Revenue

Figure 23 Novartis AG: Key Financials

Figure 24 Novartis AG: Segmental Revenue

Figure 25 Novartis AG: Geographical Revenue

Figure 26 Merck & Co., Inc: Key Financials

Figure 27 Merck & Co., Inc: Segmental Revenue

Figure 28 Merck & Co., Inc: Geographical Revenue

Figure 29 GlaxoSmithKline: Key Financials

Figure 30 GlaxoSmithKline: Segmental Revenue

Figure 31 GlaxoSmithKline: Geographical Revenue

Figure 32 Pharmascience Inc.: Key Financials

Figure 33 Pharmascience Inc.: Segmental Revenue

Figure 34 Pharmascience Inc.: Geographical Revenue